Timing of Graves’ Hyperthyroidism Management in Pregnant Women: Impact on the Infant Thyroid Volume
The thyroid of the fetus of a mother with Graves’ disease (GD) is affected by the transplacental passage of both antithyroid drugs (ATDs) and thyroid-stimulating hormone receptor antibodies (TRAb). Thyroid hormone imbalances are harmful for the developing brain. This study aimed to evaluate the impa...
Main Authors: | Aleksandra Mikołajczak, Renata Bokiniec |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/14/9/1972 |
Similar Items
-
Correlation Between Thyroid Hormone Concentrations and Ultrasound Thyroid Volume in Preterm Infants Born Before 33 Weeks of Gestation
by: Aleksandra Mikołajczak, et al.
Published: (2022-05-01) -
Hyperthyroidism in adolescents
by: Marek Niedziela
Published: (2021-10-01) -
Pharmacological Survey of Graves\' Disease: A Mini Review
by: Akhtar Saifi, et al.
Published: (2021-04-01) -
Long-term outcomes of graves disease in children treated with anti-thyroid drugs
by: Ya-Ting Chiang, et al.
Published: (2020-06-01) -
Long-term follow-up result of antithyroid drug treatment of Graves’ hyperthyroidism in a large cohort
by: Meihua Jin, et al.
Published: (2023-03-01)